GlassScriptPhysician profile
Magda S Williams
NPI 1104875822
$3,346.14
in general payments reported to CMS, 2019-2025
27 companies · $213 in 2025
The $213 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,714 · 2020: $354 · 2021: $64.43 · 2022: $110 · 2023: $606 · 2024: $285 · 2025: $213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,085 · Entertainment: $18.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,084.89 |
| Entertainment | $18.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $991.28 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Amgen INC. | $564.15 | 2019-2021 | |
| Abbvie INC. | $424.92 | 2019-2023 | Vraylar, Linzess, Viberzi |
| Boston Scientific Corporation | $259.10 | 2023 | Watchman Access System, Watchman Flx |
| Allergan, INC. | $148.89 | 2019-2020 | |
| Medartis INC. | $111.49 | 2020 | |
| Lilly USA, LLC | $84.16 | 2019 | |
| Medtronic, INC. | $83.65 | 2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim |
| Intuitive Surgical, INC. | $77.89 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $76.67 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $66.82 | 2019 | |
| Glaxosmithkline, LLC. | $59.96 | 2019 | |
| Shield Therapeutics INC | $47.77 | 2022-2023 | Accrufer |
| Merck Sharp & Dohme LLC | $42.59 | 2019-2020 | |
| Novo Nordisk INC | $39.28 | 2022-2023 | Wegovy |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $38.08 | 2024-2025 | |
| Nestle Healthcare Nutrition INC. | $36.08 | 2021 | |
| Noven Therapeutics, LLC | $35.56 | 2025 | Xelstrym |
| Astellas Pharma US INC | $22.12 | 2020 | |
| Biogen, INC. | $18.91 | 2019 | |
| Abbott Laboratories | $18.82 | 2023 | Proclaim |
| Optos, INC. | $18.59 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Intra-Sana Laboratories | $16.28 | 2025 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Ironwood Pharmaceuticals, INC | $16.20 | 2019 | |
| Melinta Therapeutics, LLC | $15.87 | 2019 | |
| Redhill Biopharma INC. | $15.85 | 2020 | |
| Janssen Pharmaceuticals, INC | $15.16 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Magda Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.